Literature DB >> 2793215

Arginine vasopressin-induced hypertrophy of cultured rat aortic smooth muscle cells.

A A Geisterfer1, G K Owens.   

Abstract

Recently we reported that the contractile agonist angiotensin II induces hypertrophy, not hyperplasia, in cultured rat aortic smooth muscle cells (Geisterfer AAT, Peach MJ, Owens GK: Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988;62:749-756). We have further explored the hypothesis that contractile agonists are important regulators of smooth muscle cell growth by examining the effects of another contractile agonist, arginine vasopressin, on growth of cultured rat aortic smooth muscle cells. Autoradiographic analysis as well as cell number determinations showed that arginine vasopressin (1 microM) did not stimulate proliferation in cells made quiescent in a defined serum-free media nor did it augment proliferation in 0.4% fetal bovine serum. However, flow cytometric analysis of cellular protein content demonstrated that arginine vasopressin (1 microM) did induce cellular hypertrophy in quiescent cultures after 4 days of treatment, increasing smooth muscle cell protein content by 35% as compared with vehicle-treated controls. The increase in protein content showed a concentration dependence. Cellular hypertrophy was accompanied by an increase in [35S]methionine incorporation, which was elevated 45% by 24 hours. Both the increase in [35S]methionine incorporation and the increase in protein content could be prevented by the specific arginine vasopressin receptor antagonist. [1-beta-mercapto-beta,beta-cyclopentamethylene propionic acid), 2-(O-methyl)tyrosine] arginine vasopressin. An increase in [35S]methionine incorporation was observed between 12 and 24 hours after treatment of quiescent smooth muscle cells for only 5 minutes with arginine vasopressin (1 microM). Arginine vasopressin-induced increases in [35S]methionine incorporation was increased within 6 hours after treatment. These studies show that arginine vasopressin, like angiotensin II, induces hypertrophy but not hyperplasia of cultured rat aortic smooth muscle cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2793215     DOI: 10.1161/01.hyp.14.4.413

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  6 in total

Review 1.  Protein kinase C isoenzymes: a review of their structure, regulation and role in regulating airways smooth muscle tone and mitogenesis.

Authors:  B L Webb; S J Hirst; M A Giembycz
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

2.  Arginine vasopressin increases the rate of protein synthesis in isolated perfused adult rat heart via the V1 receptor.

Authors:  J Fukuzawa; T Haneda; K Kikuchi
Journal:  Mol Cell Biochem       Date:  1999-05       Impact factor: 3.396

Review 3.  Protein tyrosine phosphorylation in cardiovascular system.

Authors:  A K Srivastava
Journal:  Mol Cell Biochem       Date:  1995 Aug-Sep       Impact factor: 3.396

4.  Angiotensin II stimulates protein-tyrosine phosphorylation in a calcium-dependent manner.

Authors:  W R Huckle; C A Prokop; R C Dy; B Herman; S Earp
Journal:  Mol Cell Biol       Date:  1990-12       Impact factor: 4.272

5.  Troglitazone and pioglitazone attenuate agonist-dependent Ca2+ mobilization and cell proliferation in vascular smooth muscle cells.

Authors:  M Asano; T Nakajima; K Iwasawa; T Morita; F Nakamura; H Imuta; K Chisaki; N Yamada; M Omata; Y Okuda
Journal:  Br J Pharmacol       Date:  1999-10       Impact factor: 8.739

6.  Arginine vasopressin: Direct and indirect action on metabolism.

Authors:  Mitsuhiro Yoshimura; Becky Conway-Campbell; Yoichi Ueta
Journal:  Peptides       Date:  2021-04-24       Impact factor: 3.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.